Evidence map›Paper›PMID 33357513›Full record

ArticleAmerican journal of human genetics2021

Host genetic effects in pneumonia.

Hung-Hsin Chen, Douglas M Shaw, Lauren E Petty, Misa Graff, Ryan J Bohlender, Hannah G Polikowsky, Xue Zhong, Daeeun Kim, Victoria L Buchanan, Michael H Preuss and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Unveiling the Prognostic Power of HRR in ICU-Admitted COPD Patients: A MIMIC-IV Database Study.International journal of chronic obstructive pulmonary disease · 2025
    Article
  9. NTCdb: Single-cell transcriptome database of human inflammatory-associated diseases.Computational and structural biotechnology journal · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Severe COVID-19 in Hospitalized Carriers of SingleJournal of personalized medicine · 2021
    Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Hung-Hsin ChenVanderbilt Genetics Institute and Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Douglas M ShawVanderbilt Genetics Institute and Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Lauren E PettyVanderbilt Genetics Institute and Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Misa GraffDepartment of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27516, USA.
Ryan J BohlenderDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA.
Hannah G PolikowskyVanderbilt Genetics Institute and Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Xue ZhongVanderbilt Genetics Institute and Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Daeeun KimDepartment of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27516, USA.
Victoria L BuchananDepartment of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27516, USA.
Michael H PreussThe Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Megan M ShueyVanderbilt Genetics Institute and Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Ruth J F LoosThe Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Chad D HuffDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA.
Nancy J CoxVanderbilt Genetics Institute and Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Julie A BastaracheAllergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Lisa BastaracheDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Kari E NorthDepartment of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27516, USA.
Jennifer E BelowVanderbilt Genetics Institute and Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Electronic address: jennifer.e.below@vanderbilt.edu.
Vanderbilt University Medical Center · USUniversity of North Carolina at Chapel Hill · USIcahn School of Medicine at Mount Sinai · USThe University of Texas MD Anderson Cancer Center · USVanderbilt University · US

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
The Genetic Epidemiology of Heart, Lung, and Blood TraitsTraining Grant (GenHLB)T32HL129982 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Christy Leigh Avery, KAREN L. MOHLKE · 2016 to 2026
$3.8M
Training Program on Genetic Variation and Human PhenotypesT32GM080178 · NIGMS · VANDERBILT UNIVERSITY · PI COX, NANCY J, SAMUELS, DAVID C · 2007 to 2021
$3.1M
Harnessing the power of genetic relatedness for disease gene discoveryR01GM133169 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BELOW, JENNIFER, HUFF, CHAD DANIEL · 2019 to 2022
$2.6M
Modular Automated -80C Sample Storage SystemS10OD025092 · OD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GOLDENRING, JAMES RICHARD · 2019 to 2019
$2.0M
NCATS NIH HHS UL1 TR002243NHLBI NIH HHS T32 HL129982NIGMS NIH HHS R01 GM133169NIGMS NIH HHS T32 GM080178NIH HHS S10 OD025092
6 · The paper itself

Abstract

Given the coronavirus disease 2019 (COVID-19) pandemic, investigations into host susceptibility to infectious diseases and downstream sequelae have never been more relevant. Pneumonia is a lung disease that can cause respiratory failure and hypoxia and is a common complication of infectious diseases, including COVID-19. Few genome-wide association studies (GWASs) of host susceptibility and severity of pneumonia have been conducted. We performed GWASs of pneumonia susceptibility and severity in the Vanderbilt University biobank (BioVU) with linked electronic health records (EHRs), including Illumina Expanded Multi-Ethnic Global Array (MEGA

Indexed as

BronchitisCOVID-19Cystic Fibrosis Transmembrane Conductance RegulatorDatabases, GeneticElectronic Health RecordsFemaleGenome-Wide Association StudyGenotypeHemoglobinsHost-Pathogen InteractionsHumansInpatientsLinkage DisequilibriumMaleOutpatientsPneumonia, ViralCFTR protein, humanCystic Fibrosis Transmembrane Conductance Regulatorhemoglobin BHemoglobinsbiobankelectronic health recordGWAShost genetic effectpneumonia

Identifiers

PMID33357513
PMCPMC7820802
OpenAlexW3111164586

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.